eB2BMart

Hepcdac Daclatasvir Tablets

₹2,000.00 / Bottle

Specification

form
Tablet
brand
Cipla
treatment
Used along with other medications for the treatment of chronic hepatitis C virus (HCV) infection
shelf life
24 Months
composition
Daclatasvir
dosage form
Tablet
indications
Cure The Hepatitis C Virus
availability
In Stock
packaging size
28 Tablet
packaging type
Box
strength dosage
60 mg
Add Quantity
Bottle
Response within 4 hoursFree to enquire

Description

Hepcdac is used with another antiviral medication (sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. These medications together reduce the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer. On using this medication you may experience side effects such as nausea, headache, weakness, fatigue, breakdown of the red cell, diarrhoea, drowsiness, dizziness and skin rash. If your reactions persist or become worse over time seek the help of your health care provider right away. The dosage should be determined by the doctor based on your age, overall medical history and current condition. The usual dose in adults for treating chronic hepatitis C is 60 mg, taken orally once daily for a period of 12 weeks. Product Description: Expiry – 1 Year to 2 Years Indication(s) – Hepatitic C Virus (HCV) Infection UPC / GTIN Barcode – No Prescription Required – Yes

Verify supplier credentials before transacting. Enquiries create leads for the supplier.